EP2766395
MÓTEFNAFJÖLPEPTÍÐ SEM BLOKKA CD40L
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
12.10.2012EP published:
20.11.2019EP application number:
12775423.2
EP translation filed:
13.2.2020Grant published:
15.3.2020EPO information:
European Patent Register
Max expiry date:
11.10.2032Expiry date:
11.10.2021
Title:
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L
Timeline
Today
12.10.2012EP application
20.11.2019EP Publication
13.2.2020Translation submitted
15.3.2020Registration published
11.10.2021Expires
Owner
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, 08543, Princeton, NJ, US
Name:
Domantis LimitedAddress:
980 Great West Road, Brentford, Middlesex TW8 9GS, GB
Inventor
Name:
NADLER, Steven G.Address:
Princeton, New Jersey, US
Name:
TAMURA, James K.Address:
Yardley, PA, US
Name:
PRICE, LauraAddress:
Langhorne, PA, US
Name:
REHFUSS, Robert P.Address:
North Wales, PA, US
Name:
SUCHARD, Suzanne J.Address:
Princeton, New Jersey, US
Name:
SURI, AnishAddress:
Yardley, PA, US
Name:
BRYSON, James WilliamAddress:
Princeton, New Jersey, US
Name:
YAMNIUK, AaronAddress:
Princeton, New Jersey, US
Name:
GRANT, StevenAddress:
CambridgeCambridgeshire CB4 0WG, GB
Name:
IGNATOVICH, OlgaAddress:
CambridgeCambridgeshire CB4 0WG, GB
Name:
DREW, PhilipAddress:
CambridgeCambridgeshire CB4 0WG, GB
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201161546800 PDate:
13.10.2011Country:
US
Number:
201261655110 PDate:
4.6.2012Country:
US
Classification
Categories:
C07K 16/28, A61K 39/395
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 9.9.2020
Expires: 11.10.2021
Payer: Árnason Faktor ehf.